AKT signaling in ERBB2-amplified breast cancer. - Wikidata - wikimedia - TriplyDB

AKT signaling in ERBB2-amplified breast cancer.

AKT signaling in ERBB2-amplified breast cancer.

http://www.wikidata.org/entity/Q36563578

about

The Antibiotic Drug Tigecycline: A Focus on its Promising Anticancer Properties Comparison of the PI3KCA pathway in circulating tumor cells and corresponding tumor tissue of patients with metastatic breast cancer.EFEMP1 promotes ovarian cancer cell growth, invasion and metastasis via activated the AKT pathway.Controlling Directed Protein Interaction Networks in Cancer.Identification of an HSP90 modulated multi-step process for ERBB2 degradation in breast cancer cells.Metabolic syndrome in rats is associated with erectile dysfunction by impairing PI3K/Akt/eNOS activity.MiR-1268b confers chemosensitivity in breast cancer by targeting ERBB2-mediated PI3K-AKT pathway.Combined inhibition of AKT and HSF1 suppresses breast cancer stem cells and tumor growth.Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer.Raddeanin A suppresses breast cancer-associated osteolysis through inhibiting osteoclasts and breast cancer cells.20(S)-Protopanaxadiol-Induced Apoptosis in MCF-7 Breast Cancer Cell Line through the Inhibition of PI3K/AKT/mTOR Signaling Pathway.

P2860

Q28076402-19B266AD-5CC3-4B9B-9D1F-41A1672632B9 Q33674656-E9B46AF0-EC9B-434D-9E87-C654D9B429E9 Q37565332-151111EE-CB75-416A-99E7-3ACB0447BE47 Q41605713-51BBAAA7-FD73-4F0C-B2A0-60E1208E36F9 Q41773399-D3D4BCFB-DB7B-4FBA-A51E-67FB45A3C885 Q42677598-3C40EEAE-C446-494E-A96A-199A15678B77 Q47107454-776CB6F5-E8C5-4E4D-A1A9-5906B8848ECA Q47121469-485B64F7-F457-4E0B-AD60-C7274516269D Q47564750-70978ECD-08B5-449C-8B15-D0F224C039F4 Q52668582-88152C0F-5C7B-4FD5-B509-84431BF86A96 Q52721972-414CA40F-00F6-4238-B71A-829EB2884DFF

P2860

AKT signaling in ERBB2-amplified breast cancer.

http://www.wikidata.org/entity/Q36563578

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

AKT signaling in ERBB2-amplified breast cancer.

@ast

AKT signaling in ERBB2-amplified breast cancer.

@en

type

label

AKT signaling in ERBB2-amplified breast cancer.

@ast

AKT signaling in ERBB2-amplified breast cancer.

@en

prefLabel

AKT signaling in ERBB2-amplified breast cancer.

@ast

AKT signaling in ERBB2-amplified breast cancer.

@en

P1433

Q36563578-94C9ABA7-9D07-42BC-A367-C8A5C621AB1C

P1476

Q36563578-9807A220-9314-4DA6-B4F5-1942F64078B9

P2093

Q36563578-18F3B508-9871-4F06-A4B5-BFE99A85F454

Q36563578-2304EEA5-C2E7-42C0-9724-730AB5E7C660

Q36563578-27A17734-9CB8-4CA8-83FE-83FAAA6E3901

Q36563578-49A53743-3708-4E09-8EF5-FC73CB18A5EC

Q36563578-9F187F28-A32B-4418-8D75-1F1A25114110

Q36563578-A931DFEE-278F-4166-91C0-16BB8FF97F4B

P2860

Q36563578-01C018D7-BBA2-43C7-8D90-BC813955FDB8

Q36563578-07035736-6C53-4E4D-9CAA-C1D0BDB60A0D

Q36563578-0C9C204B-4CE6-4C15-ADF6-626658604FAB

Q36563578-0DD027F6-D463-4787-851D-6EF9852DA33D

Q36563578-0EF98FB5-38B2-4571-B0A0-0C0C26C90B18

Q36563578-0F5BC399-4DC6-40CD-8622-49A0434D75A0

Q36563578-0FE44E82-350E-4976-BD9C-7C0313B71287

Q36563578-12669A29-84CA-43A8-8CAF-5848A45458BA

Q36563578-1431F6A2-47B8-4B29-85F8-B29A53999072

Q36563578-18F2011E-AB28-48F1-99E2-7B9749C41768

P304

Q36563578-2F28B174-6C5F-4600-A53D-BF9BFA8DEF37

P31

Q36563578-324EFF8A-7800-488D-87CA-03C2A3972372

P356

Q36563578-497615DA-1480-425C-BD82-06D70917803B

P478

Q36563578-B7801E48-07BF-4970-85FF-1C56E432789C

P50

Q36563578-843BDEEA-7821-4E58-BA42-15CC21E95617

P577

Q36563578-BD6C1972-8212-4427-8E8F-D567C53C1307

P698

Q36563578-4D490F71-9966-431D-85D7-3828190DF970

P932

Q36563578-762CEA9D-D869-469B-841E-6FA307B58398

P356

J.PHARMTHERA.2015.11.013

P1433

Pharmacology & Therapeutics

P1476

AKT signaling in ERBB2-amplified breast cancer.

@en

P2093

Chandra Verma

http://www.w3.org/2001/XMLSchema#string

F Javier Carmona

http://www.w3.org/2001/XMLSchema#string

José Baselga

http://www.w3.org/2001/XMLSchema#string

Maurizio Scaltriti

http://www.w3.org/2001/XMLSchema#string

Srinivasaraghavan Kannan

http://www.w3.org/2001/XMLSchema#string

Valentina Rossi

http://www.w3.org/2001/XMLSchema#string

P2860

The lipid phosphatase activity of PTEN is critical for its tumor supressor function

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms

Mechanism of activation of protein kinase B by insulin and IGF-1

Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP

PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer

Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases

Comprehensive molecular portraits of human breast tumours

Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen

P304

63-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PHARMTHERA.2015.11.013

http://www.w3.org/2001/XMLSchema#string

P478

158

http://www.w3.org/2001/XMLSchema#string

P50

Filippo Montemurro

P577

2015-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26645663

http://www.w3.org/2001/XMLSchema#string

P932

4747800

http://www.w3.org/2001/XMLSchema#string